Therapeutic effects of a new, anti-allergic ophthalmic preparation.
A 0.1% Ketotifen ophthalmic preparation was evaluated in 11 cases of conjunctivitis due to Japanese cedar pollinoisis (three cases also associated with vernal catarrh). The following results were obtained concerning the safety and the therapeutic efficacy of the preparation. (1) In the computation of the overall effects of the preparation, a marked therapeutic effect was noted in three out of 11 cases studied while one case remained unaffected. The overall effective rate was computed to be 91%. (2) The time required for the preparation to take effect was found to be 3 days or less in seven cases (70.0%) out of 10 in which therapeutic effects were noted. (3) In observations of the adverse effects of the preparation, transient irritation at the site of application was noted in seven cases. No other serious side effects were recorded. From the above results, it was concluded that the present preparation is an effective therapeutic agent for conjunctivitis caused by pollinosis.
D000818:Animals; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D007665:Ketotifen / Q000008:administration & dosage / Q000627:therapeutic use*; D009824:Ointments; D011058:Pollen; D011817:Rabbits; D014197:Trees
D009824:Ointments; D007665:Ketotifen